Literature DB >> 1945879

One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.

K Briegel1, B Hentsch, I Pfeuffer, E Serfling.   

Abstract

The inducible, T cell-specific enhancers of murine and human Interleukin 2 (Il-2) genes contain the kB-like sequence GGGATTTCACC as an essential cis-acting enhancer motif. When cloned in multiple copies this so-called TCEd (distal T cell element) acts as an inducible proto-enhancer element in E14 T lymphoma cells, but not in HeLa cells. In extracts of induced, Il-2 secreting El4 cells three individual protein factors bind to TCEd DNA. The binding of the most prominent factor, named TCF-1 (T cell factor 1), is correlated with the proto-enhancer activity of TCEd. TCF-1 consists of two polypeptides of about 50 kD and 105 kD; the former seems to be related to the 50 kD polypeptide of NF-kB. Purified NF-kB is also able to bind to the TCEd, but TCF-1 binds stronger than NF-kB to TCEd DNA. The conversion of the TCEd to a 'perfect' NF-kB binding site leads to a tighter binding of NF-kB to TCEd DNA and, as a functional consequence, to the activity of the 'converted' TCEd motifs in HeLa cells. Thus, the substitution of the underlined A residue to a C within the GGGATTTCACC motif abolishes its T cell-restricted activity and leads to its functioning in both El4 cells and HeLa cells. These results indicate that lymphocyte-specific factors binding to the TCEd are involved in the control of T cell specific-transcription of the Il-2 gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1945879      PMCID: PMC329049          DOI: 10.1093/nar/19.21.5929

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  36 in total

1.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements.

Authors:  B Luckow; G Schütz
Journal:  Nucleic Acids Res       Date:  1987-07-10       Impact factor: 16.971

2.  Affinity purification of sequence-specific DNA binding proteins.

Authors:  J T Kadonaga; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Purification and biochemical characterization of the promoter-specific transcription factor, Sp1.

Authors:  M R Briggs; J T Kadonaga; S P Bell; R Tjian
Journal:  Science       Date:  1986-10-03       Impact factor: 47.728

4.  Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element.

Authors:  J W Pierce; M Lenardo; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Regulation of human interleukin-2 gene: functional DNA sequences in the 5' flanking region for the gene expression in activated T lymphocytes.

Authors:  T Fujita; H Shibuya; T Ohashi; K Yamanishi; T Taniguchi
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

6.  Involvement of a common transcription factor in the regulated expression of IL-2 and IL-2 receptor genes.

Authors:  H Shibuya; M Yoneyama; T Taniguchi
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

7.  High efficiency polyoma DNA transfection of chloroquine treated cells.

Authors:  H Luthman; G Magnusson
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV.

Authors:  E Böhnlein; J W Lowenthal; M Siekevitz; D W Ballard; B R Franza; W C Greene
Journal:  Cell       Date:  1988-06-03       Impact factor: 41.582

9.  A 275 basepair fragment at the 5' end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor.

Authors:  D B Durand; M R Bush; J G Morgan; A Weiss; G R Crabtree
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

10.  The structure and expression of the murine gene encoding granulocyte-macrophage colony stimulating factor: evidence for utilisation of alternative promoters.

Authors:  E Stanley; D Metcalf; P Sobieszczuk; N M Gough; A R Dunn
Journal:  EMBO J       Date:  1985-10       Impact factor: 11.598

View more
  11 in total

1.  Characterization of the mouse dynamin I gene promoter and identification of sequences that direct expression in neuronal cells.

Authors:  J Yoo; S S Lee; M J Jeong; K I Lee; B M Kwon; S H Kim; Y M Park; M Y Han
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

2.  Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas.

Authors:  David M Dorfman; Harvey A Greisman; Aliakbar Shahsafaei
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  The weak, fine-tuned binding of ubiquitous transcription factors to the Il-2 enhancer contributes to its T cell-restricted activity.

Authors:  B Hentsch; A Mouzaki; I Pfeuffer; D Rungger; E Serfling
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

4.  Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions.

Authors:  S B Ward; G Hernandez-Hoyos; F Chen; M Waterman; R Reeves; E V Rothenberg
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

5.  Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter.

Authors:  S Chuvpilo; C Schomberg; R Gerwig; A Heinfling; R Reeves; F Grummt; E Serfling
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

6.  Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site.

Authors:  T Brabletz; I Pfeuffer; E Schorr; F Siebelt; T Wirth; E Serfling
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

7.  Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors.

Authors:  P A Garrity; D Chen; E V Rothenberg; B J Wold
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

8.  Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation.

Authors:  Martin Leverkus; Martin R Sprick; Tina Wachter; Thilo Mengling; Bernd Baumann; Edgar Serfling; Eva-B Bröcker; Matthias Goebeler; Manfred Neumann; Henning Walczak
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

9.  IL-2 Expression in Activated Human Memory FOXP3(+) Cells Critically Depends on the Cellular Levels of FOXP3 as Well as of Four Transcription Factors of  T Cell Activation.

Authors:  Hanna Bendfeldt; Manuela Benary; Tobias Scheel; Kerstin Steinbrink; Andreas Radbruch; Hanspeter Herzel; Ria Baumgrass
Journal:  Front Immunol       Date:  2012-08-27       Impact factor: 7.561

10.  RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A.

Authors:  M Neumann; T Grieshammer; S Chuvpilo; B Kneitz; M Lohoff; A Schimpl; B R Franza; E Serfling
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.